SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.75 |
| Enterprise Value ($M) | 3.18 |
| Book Value ($M) | -0.71 |
| Book Value / Share | -0.17 |
| Price / Book | -5.26 |
| NCAV ($M) | -0.78 |
| NCAV / Share | -0.18 |
| Price / NCAV | -4.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -3.26 |
| Return on Equity (ROE) | -23.84 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.70 |
| Current Ratio | 0.86 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.90 |
| Assets | 2.96 |
| Liabilities | 3.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Intracoastal Capital, Llc | 4.99 | 262.87 | |
| 13G/A | Hudson Bay Capital Management LP | 1.35 | -95.07 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 18,024 | 71,470 | 25.22 | |
| 13,948 | 94,077 | 14.83 | |
| 7,880 | 90,347 | 8.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BNTC – Benitec Biopharma Inc. | BOLT – Bolt Biotherapeutics, Inc. |
| BON – Bon Natural Life Limited | BTAI – BioXcel Therapeutics, Inc. |
| BYSI – BeyondSpring Inc. |
Financial data and stock pages provided by
Fintel.io